Evaluation of alternative methods of cervical cancer screening for resource‐poor settings

BACKGROUND Noncytologic methods of screening for cervical carcinoma and its precursor lesions are needed for resource‐poor settings in which cervical carcinoma continues to be an important cause of morbidity and mortality. METHODS Two thousand nine hundred forty‐four women ages 35–65 years were recr...

Full description

Saved in:
Bibliographic Details
Published inCancer Vol. 89; no. 4; pp. 826 - 833
Main Authors Denny, Lynette, Kuhn, Louise, Pollack, Amy, Wainwright, Helen, Wright, Thomas C.
Format Journal Article
LanguageEnglish
Published New York John Wiley & Sons, Inc 15.08.2000
Wiley-Liss
Subjects
Online AccessGet full text

Cover

Loading…
Abstract BACKGROUND Noncytologic methods of screening for cervical carcinoma and its precursor lesions are needed for resource‐poor settings in which cervical carcinoma continues to be an important cause of morbidity and mortality. METHODS Two thousand nine hundred forty‐four women ages 35–65 years were recruited from Cape Town, South Africa and screened using a combination of a Papanicolaou (Pap) smear, human papillomavirus (HPV) DNA testing, direct visual inspection after the application of a 5% acetic acid solution (DVI), and cervicography. Cervicography was considered primarily as a method with which to quality control the DVI examinations. Women with squamous intraepithelial lesions (SIL) or carcinoma on Pap smear, positive DVI examination (acetowhite lesion or cervical ulcer/growth), high levels of high risk HPV DNA (relative light units [RLU] > 10× positive control), or positive Cervigram™ were referred for colposcopy and cervical biopsy. RESULTS Pap smears were positive in 8.1% of all women screened and identified 65 (78%) of all cases of biopsy confirmed high grade disease (high grade SIL or invasive carcinoma). DVI and cervicography were classified as positive in 18.1% and 10.5%, respectively, of women screened and identified 58 (67%) and 46 (58%) of all cases of high grade disease, respectively. The results of HPV DNA testing varied depending on the cutoff value used to define a positive result. At the standard cutoff level (RLU > 1× positive control), 16.2% of women screened were classified as high risk HPV DNA positive, as were 63 women with high grade disease (73%). CONCLUSIONS DVI and HPV DNA testing identified similar numbers of high grade SIL (cervical intraepithelial neoplasia Grade 2,3) and invasive carcinoma cases as Pap smears. However, both classify considerably more women without cervical disease as being test positive. Cancer 2000;89:826–33. © 2000 American Cancer Society. Direct visual inspection and human papillomavirus DNA testing identify similar numbers of cases of high grade squamous intraepithelial lesions (cervical intraepithelial neoplasia Grade 2,3) and invasive cervical carcinoma as does Papanicolaou smear screening. However, both methods classify considerably more women without cervical disease as being test positive.
AbstractList BACKGROUNDNoncytologic methods of screening for cervical carcinoma and its precursor lesions are needed for resource-poor settings in which cervical carcinoma continues to be an important cause of morbidity and mortality.METHODSTwo thousand nine hundred forty-four women ages 35-65 years were recruited from Cape Town, South Africa and screened using a combination of a Papanicolaou (Pap) smear, human papillomavirus (HPV) DNA testing, direct visual inspection after the application of a 5% acetic acid solution (DVI), and cervicography. Cervicography was considered primarily as a method with which to quality control the DVI examinations. Women with squamous intraepithelial lesions (SIL) or carcinoma on Pap smear, positive DVI examination (acetowhite lesion or cervical ulcer/growth), high levels of high risk HPV DNA (relative light units [RLU] > 10x positive control), or positive Cervigramtrade mark were referred for colposcopy and cervical biopsy.RESULTSPap smears were positive in 8.1% of all women screened and identified 65 (78%) of all cases of biopsy confirmed high grade disease (high grade SIL or invasive carcinoma). DVI and cervicography were classified as positive in 18.1% and 10.5%, respectively, of women screened and identified 58 (67%) and 46 (58%) of all cases of high grade disease, respectively. The results of HPV DNA testing varied depending on the cutoff value used to define a positive result. At the standard cutoff level (RLU > 1x positive control), 16.2% of women screened were classified as high risk HPV DNA positive, as were 63 women with high grade disease (73%).CONCLUSIONSDVI and HPV DNA testing identified similar numbers of high grade SIL (cervical intraepithelial neoplasia Grade 2,3) and invasive carcinoma cases as Pap smears. However, both classify considerably more women without cervical disease as being test positive.
BACKGROUND Noncytologic methods of screening for cervical carcinoma and its precursor lesions are needed for resource‐poor settings in which cervical carcinoma continues to be an important cause of morbidity and mortality. METHODS Two thousand nine hundred forty‐four women ages 35–65 years were recruited from Cape Town, South Africa and screened using a combination of a Papanicolaou (Pap) smear, human papillomavirus (HPV) DNA testing, direct visual inspection after the application of a 5% acetic acid solution (DVI), and cervicography. Cervicography was considered primarily as a method with which to quality control the DVI examinations. Women with squamous intraepithelial lesions (SIL) or carcinoma on Pap smear, positive DVI examination (acetowhite lesion or cervical ulcer/growth), high levels of high risk HPV DNA (relative light units [RLU] > 10× positive control), or positive Cervigram™ were referred for colposcopy and cervical biopsy. RESULTS Pap smears were positive in 8.1% of all women screened and identified 65 (78%) of all cases of biopsy confirmed high grade disease (high grade SIL or invasive carcinoma). DVI and cervicography were classified as positive in 18.1% and 10.5%, respectively, of women screened and identified 58 (67%) and 46 (58%) of all cases of high grade disease, respectively. The results of HPV DNA testing varied depending on the cutoff value used to define a positive result. At the standard cutoff level (RLU > 1× positive control), 16.2% of women screened were classified as high risk HPV DNA positive, as were 63 women with high grade disease (73%). CONCLUSIONS DVI and HPV DNA testing identified similar numbers of high grade SIL (cervical intraepithelial neoplasia Grade 2,3) and invasive carcinoma cases as Pap smears. However, both classify considerably more women without cervical disease as being test positive. Cancer 2000;89:826–33. © 2000 American Cancer Society. Direct visual inspection and human papillomavirus DNA testing identify similar numbers of cases of high grade squamous intraepithelial lesions (cervical intraepithelial neoplasia Grade 2,3) and invasive cervical carcinoma as does Papanicolaou smear screening. However, both methods classify considerably more women without cervical disease as being test positive.
Noncytologic methods of screening for cervical carcinoma and its precursor lesions are needed for resource-poor settings in which cervical carcinoma continues to be an important cause of morbidity and mortality. Two thousand nine hundred forty-four women ages 35-65 years were recruited from Cape Town, South Africa and screened using a combination of a Papanicolaou (Pap) smear, human papillomavirus (HPV) DNA testing, direct visual inspection after the application of a 5% acetic acid solution (DVI), and cervicography. Cervicography was considered primarily as a method with which to quality control the DVI examinations. Women with squamous intraepithelial lesions (SIL) or carcinoma on Pap smear, positive DVI examination (acetowhite lesion or cervical ulcer/growth), high levels of high risk HPV DNA (relative light units [RLU] > 10x positive control), or positive Cervigramtrade mark were referred for colposcopy and cervical biopsy. Pap smears were positive in 8.1% of all women screened and identified 65 (78%) of all cases of biopsy confirmed high grade disease (high grade SIL or invasive carcinoma). DVI and cervicography were classified as positive in 18.1% and 10.5%, respectively, of women screened and identified 58 (67%) and 46 (58%) of all cases of high grade disease, respectively. The results of HPV DNA testing varied depending on the cutoff value used to define a positive result. At the standard cutoff level (RLU > 1x positive control), 16.2% of women screened were classified as high risk HPV DNA positive, as were 63 women with high grade disease (73%). DVI and HPV DNA testing identified similar numbers of high grade SIL (cervical intraepithelial neoplasia Grade 2,3) and invasive carcinoma cases as Pap smears. However, both classify considerably more women without cervical disease as being test positive.
Author Denny, Lynette
Kuhn, Louise
Wright, Thomas C.
Wainwright, Helen
Pollack, Amy
Author_xml – sequence: 1
  givenname: Lynette
  surname: Denny
  fullname: Denny, Lynette
– sequence: 2
  givenname: Louise
  surname: Kuhn
  fullname: Kuhn, Louise
– sequence: 3
  givenname: Amy
  surname: Pollack
  fullname: Pollack, Amy
– sequence: 4
  givenname: Helen
  surname: Wainwright
  fullname: Wainwright, Helen
– sequence: 5
  givenname: Thomas C.
  surname: Wright
  fullname: Wright, Thomas C.
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=1448902$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/10951346$$D View this record in MEDLINE/PubMed
BookMark eNqVkNFqFDEUhoNU7Lb6CjIXInox22SSzCRbEcpYbaG4UBQELw7ZzImOzE7WZGaldz5Cn7FPYoZdqxfeGALJf_KfP4fviBz0vkdCFozOGaXFCaO6yikTxYuCpqWYfKn0QrxSRblYnF2-yev39TWTr_mczuvlaZHLB2R233RAZlNTLgX_dEiOYvyWZFVI_ogcJpNkXJQz8vl8a7rRDK3vM-8y0w0Y-iS3mK1x-OqbOJUthm1rTZdZ06d7Fm1A7Nv-S-Z8yAJGPwaLdz9vNz7piMOQ3uJj8tCZLuKT_XlMPr49_1Bf5FfLd5f12VVuJacy55LLklqdNpd0xUrlLDbOVsKipNaVkuqmWmmFotS2oq5aVWhcoxRvrKwMPybPd7mb4L-PGAdYt9Fi15ke_RihKphWlIpkvN4ZbfAxBnSwCe3ahBtgFCbkMNGDiR78Rg5Kg4CEHCAhhx1y4EChXkIBMoU-3f8-rtbY_BW5Y5wMz_YGExNDFxLDNv7xCaE0Lfg9nR9thzf_Ndk_B9tX-C81DarU
CODEN CANCAR
Cites_doi 10.1016/0046-8177(92)90338-4
10.1007/978-1-4757-3889-6_7
10.1016/S0140-6736(98)07033-0
10.1016/0029-7844(96)00189-5
10.1002/ijc.2910540413
10.1016/S0140-6736(95)91086-7
10.1002/(SICI)1097-0142(19981115)83:10<2150::AID-CNCR13>3.0.CO;2-0
10.1002/(SICI)1097-0215(19990105)80:1<161::AID-IJC28>3.0.CO;2-8
10.1016/S0895-4356(97)00122-4
10.1136/bmj.318.7186.757
10.1093/oxfordjournals.aje.a114580
ContentType Journal Article
Copyright Copyright © 2000 American Cancer Society
2000 INIST-CNRS
Copyright 2000 American Cancer Society.
Copyright_xml – notice: Copyright © 2000 American Cancer Society
– notice: 2000 INIST-CNRS
– notice: Copyright 2000 American Cancer Society.
DBID IQODW
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
DOI 10.1002/1097-0142(20000815)89:4<826::AID-CNCR15>3.0.CO;2-5
DatabaseName Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic

MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1097-0142
EndPage 833
ExternalDocumentID 10_1002_1097_0142_20000815_89_4_826__AID_CNCR15_3_0_CO_2_5
10951346
1448902
CNCR15
Genre article
Research Support, Non-U.S. Gov't
Journal Article
Comparative Study
GeographicLocations South Africa(Republic)
Africa
GrantInformation_xml – fundername: Cancer Association of South Africa
– fundername: William Gates Foundation
– fundername: Anglo‐American Chairman's Education Trust, South Africa
– fundername: AVSC International
– fundername: Department of National Health, South Africa
GroupedDBID ---
-~X
.3N
.GA
.GJ
.Y3
05W
0R~
10A
1CY
1L6
1OC
24P
29B
31~
33P
3O-
3SF
3WU
4.4
4ZD
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5GY
5VS
66C
6J9
6P2
6PF
702
7PT
8-0
8-1
8-3
8-4
8-5
85S
8UM
930
A01
A03
AAESR
AAEVG
AAHHS
AANLZ
AAONW
AARRQ
AAWTL
AAXRX
AAZKR
ABCQN
ABCUV
ABEML
ABHFT
ABIJN
ABIVO
ABJNI
ABLJU
ABOCM
ABPPZ
ABPVW
ABQWH
ABXGK
ACAHQ
ACCFJ
ACCZN
ACFBH
ACGFO
ACGFS
ACGOF
ACMXC
ACNCT
ACPOU
ACPRK
ACSCC
ACXBN
ACXQS
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADOZA
ADXAS
ADZMN
ADZOD
AEEZP
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFFNX
AFFPM
AFGKR
AFPWT
AFRAH
AFZJQ
AGNAY
AHBTC
AI.
AIACR
AIAGR
AITYG
AIURR
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AMBMR
AMYDB
ATUGU
AZBYB
AZVAB
BAFTC
BAWUL
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BY8
C45
CS3
D-6
D-7
D-E
D-F
DCZOG
DIK
DPXWK
DR2
DRFUL
DRMAN
DRSTM
E3Z
EBS
EJD
F00
F01
F04
F5P
FD6
FUBAC
G-S
G.N
GNP
GODZA
GX1
H.X
HBH
HGLYW
HHY
HHZ
HZ~
H~9
IH2
IX1
J0M
J5H
JPC
KBYEO
KQQ
KZ1
L7B
LATKE
LAW
LC2
LC3
LH4
LITHE
LOXES
LP6
LP7
LSO
LUTES
LW6
LYRES
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N4W
N9A
NEJ
NF~
NNB
O66
O9-
OHT
OIG
OK1
OVD
P2P
P2W
P2X
P2Z
P4B
P4D
Q.N
Q11
QB0
QRW
R.K
ROL
RWI
RX1
SJN
SUPJJ
TEORI
UDS
UHB
V2E
V8K
V9Y
VH1
W8V
W99
WBKPD
WH7
WHWMO
WIH
WIJ
WIK
WIN
WJL
WOHZO
WQJ
WRC
WVDHM
WXI
WXSBR
XG1
XPP
XV2
Y6R
Z0Y
ZGI
ZXP
ZZTAW
~IA
~WT
08R
AAJUZ
AAUGY
AAVGM
ABCVL
ABHUG
ABPTK
ABWRO
ACXME
ADAWD
ADDAD
AFVGU
AGJLS
AKALU
C1A
EMOBN
EX3
HF~
IQODW
LMP
RSU
RYL
WHG
XFK
YQJ
ZA5
CGR
CUY
CVF
ECM
EIF
NPM
AAMNL
AAYXX
CITATION
7X8
ID FETCH-LOGICAL-c5305-353560c90c9350b168fcedfc74ce50cf6509d7b98e469c70f7b7eafd883dc57a3
IEDL.DBID DR2
ISSN 0008-543X
IngestDate Wed Dec 04 04:59:39 EST 2024
Fri Dec 06 01:11:53 EST 2024
Sat Sep 28 08:40:44 EDT 2024
Sun Oct 29 17:08:52 EDT 2023
Sat Aug 24 00:55:06 EDT 2024
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 4
Keywords Carcinoma
Cervical smear
Papovaviridae
Uterine cervix
Papillomavirus
Human papillomavirus
Papanicolaou smear test
Public health
Human
Dysplasia
Premalignant lesion
Visual observation
Malignant tumor
Method
Medical screening
Female genital diseases
Virus
Photography
Pathology
DNA
Cytopathology
Acetic acid
Uterine cervix diseases
Comparative study
High malignancy
Language English
License CC BY 4.0
Copyright 2000 American Cancer Society.
http://doi.wiley.com/10.1002/tdm_license_1.1
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c5305-353560c90c9350b168fcedfc74ce50cf6509d7b98e469c70f7b7eafd883dc57a3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/1097-0142%2820000815%2989%3A4%3C826%3A%3AAID-CNCR15%3E3.0.CO%3B2-5
PMID 10951346
PQID 72198004
PQPubID 23479
PageCount 8
ParticipantIDs proquest_miscellaneous_72198004
crossref_primary_10_1002_1097_0142_20000815_89_4_826__AID_CNCR15_3_0_CO_2_5
pubmed_primary_10951346
pascalfrancis_primary_1448902
wiley_primary_10_1002_1097_0142_20000815_89_4_826_AID_CNCR15_3_0_CO_2_5_CNCR15
PublicationCentury 2000
PublicationDate 15 August 2000
PublicationDateYYYYMMDD 2000-08-15
PublicationDate_xml – month: 08
  year: 2000
  text: 15 August 2000
  day: 15
PublicationDecade 2000
PublicationPlace New York
PublicationPlace_xml – name: New York
– name: New York, NY
– name: United States
PublicationTitle Cancer
PublicationTitleAlternate Cancer
PublicationYear 2000
Publisher John Wiley & Sons, Inc
Wiley-Liss
Publisher_xml – name: John Wiley & Sons, Inc
– name: Wiley-Liss
References 1990; 2
1997; 50
1987; 125
1993; 54
1998
1996
1994
1995; 345
1992
1999; 353
1998; 83
1999; 80
1992; 23
1998; 11
1999
1999; 318
1996; 88
Wright (10.1002/1097-0142(20000815)89:4<826::AID-CNCR15>3.0.CO;2-5-BIB6) 1994
Sherman (10.1002/1097-0142(20000815)89:4<826::AID-CNCR15>3.0.CO;2-5-BIB16) 1998; 11
Miller (10.1002/1097-0142(20000815)89:4<826::AID-CNCR15>3.0.CO;2-5-BIB4) 1992
Chock (10.1002/1097-0142(20000815)89:4<826::AID-CNCR15>3.0.CO;2-5-BIB9) 1997; 50
(10.1002/1097-0142(20000815)89:4<826::AID-CNCR15>3.0.CO;2-5-BIB10) 1999; 353
Reid (10.1002/1097-0142(20000815)89:4<826::AID-CNCR15>3.0.CO;2-5-BIB5) 1990; 2
Luff (10.1002/1097-0142(20000815)89:4<826::AID-CNCR15>3.0.CO;2-5-BIB7) 1992; 23
Sanghvi (10.1002/1097-0142(20000815)89:4<826::AID-CNCR15>3.0.CO;2-5-BIB17) 1998
World Health Organization (10.1002/1097-0142(20000815)89:4<826::AID-CNCR15>3.0.CO;2-5-BIB1) 1999
Sankaranarayanan (10.1002/1097-0142(20000815)89:4<826::AID-CNCR15>3.0.CO;2-5-BIB11) 1999; 80
Schatzkin (10.1002/1097-0142(20000815)89:4<826::AID-CNCR15>3.0.CO;2-5-BIB8) 1987; 125
Megevand (10.1002/1097-0142(20000815)89:4<826::AID-CNCR15>3.0.CO;2-5-BIB14) 1996; 88
Kmietowicz (10.1002/1097-0142(20000815)89:4<826::AID-CNCR15>3.0.CO;2-5-BIB13) 1999; 318
Parkin (10.1002/1097-0142(20000815)89:4<826::AID-CNCR15>3.0.CO;2-5-BIB2) 1993; 54
Howson (10.1002/1097-0142(20000815)89:4<826::AID-CNCR15>3.0.CO;2-5-BIB3) 1996
Sankaranarayanan (10.1002/1097-0142(20000815)89:4<826::AID-CNCR15>3.0.CO;2-5-BIB12) 1998; 83
Cuzick (10.1002/1097-0142(20000815)89:4<826::AID-CNCR15>3.0.CO;2-5-BIB15) 1995; 345
References_xml – volume: 54
  start-page: 594
  issue: 4
  year: 1993
  end-page: 606
  article-title: Estimates of the worldwide incidence of eighteen major cancers in 1985
  publication-title: Int J Cancer
– volume: 80
  start-page: 161
  issue: 1
  year: 1999
  end-page: 3
  article-title: Visual inspection with acetic acid in the early detection of cervical cancer and precursors
  publication-title: Int J Cancer
– volume: 23
  start-page: 719
  issue: 7
  year: 1992
  end-page: 21
  article-title: The Bethesda System for reporting cervical/vaginal cytologic diagnoses: report of the 1991 Bethesda Workshop
  publication-title: Hum Pathol
– start-page: 229
  year: 1994
  end-page: 78
– volume: 88
  start-page: 383
  issue: 3
  year: 1996
  end-page: 6
  article-title: Acetic acid visualization of the cervix: an alternative to cytologic screening
  publication-title: Obstet Gynecol
– volume: 50
  start-page: 1211
  year: 1997
  end-page: 7
  article-title: Comparing dichotomous screening tests when individuals negative on both tests are not verified
  publication-title: J Clin Epidemiol
– volume: 2
  start-page: 87
  year: 1990
  end-page: 116
– volume: 83
  start-page: 2150
  issue: 10
  year: 1998
  end-page: 6
  article-title: Visual inspection of the uterine cervix after the application of acetic acid in the detection of cervical carcinoma and its precursors
  publication-title: Cancer
– volume: 11
  start-page: 837
  year: 1998
  end-page: 43
  article-title: Performance of liquid‐based, thin‐layer cervical cytology: correlation with reference diagnoses and human papillomavirus testing
  publication-title: Mod Pathol
– volume: 345
  start-page: 1533
  year: 1995
  end-page: 6
  article-title: Human papillomavirus testing in primary cervical screening
  publication-title: Lancet
– volume: 353
  start-page: 869
  issue: 9156
  year: 1999
  end-page: 73
  article-title: Visual inspection with acetic acid for cervical‐cancer screening: test qualities in a primary‐care setting
  publication-title: Lancet
– year: 1992
– volume: 318
  start-page: 757
  issue: 7186
  year: 1999
  article-title: Vinegar and visual inspection used to detect cervical cancer
  publication-title: BMJ
– start-page: 25
  year: 1996
  end-page: 53
– year: 1998
– year: 1999
– volume: 125
  start-page: 672
  year: 1987
  end-page: 8
  article-title: Comparing new and old screening tests when a reference procedure cannot be performed on all screenees
  publication-title: Am J Epidemiol
– volume: 23
  start-page: 719
  year: 1992
  ident: 10.1002/1097-0142(20000815)89:4<826::AID-CNCR15>3.0.CO;2-5-BIB7
  publication-title: Hum Pathol
  doi: 10.1016/0046-8177(92)90338-4
  contributor:
    fullname: Luff
– start-page: 25
  volume-title: In her lifetime: female morbidity and mortality in Sub-Saharan Africa
  year: 1996
  ident: 10.1002/1097-0142(20000815)89:4<826::AID-CNCR15>3.0.CO;2-5-BIB3
  contributor:
    fullname: Howson
– start-page: 229
  volume-title: Blaustein's pathology of the female genital tract
  year: 1994
  ident: 10.1002/1097-0142(20000815)89:4<826::AID-CNCR15>3.0.CO;2-5-BIB6
  doi: 10.1007/978-1-4757-3889-6_7
  contributor:
    fullname: Wright
– volume: 353
  start-page: 869
  year: 1999
  ident: 10.1002/1097-0142(20000815)89:4<826::AID-CNCR15>3.0.CO;2-5-BIB10
  publication-title: Lancet
  doi: 10.1016/S0140-6736(98)07033-0
– volume: 88
  start-page: 383
  year: 1996
  ident: 10.1002/1097-0142(20000815)89:4<826::AID-CNCR15>3.0.CO;2-5-BIB14
  publication-title: Obstet Gynecol
  doi: 10.1016/0029-7844(96)00189-5
  contributor:
    fullname: Megevand
– volume: 11
  start-page: 837
  year: 1998
  ident: 10.1002/1097-0142(20000815)89:4<826::AID-CNCR15>3.0.CO;2-5-BIB16
  publication-title: Mod Pathol
  contributor:
    fullname: Sherman
– volume: 54
  start-page: 594
  year: 1993
  ident: 10.1002/1097-0142(20000815)89:4<826::AID-CNCR15>3.0.CO;2-5-BIB2
  publication-title: Int J Cancer
  doi: 10.1002/ijc.2910540413
  contributor:
    fullname: Parkin
– volume: 345
  start-page: 1533
  year: 1995
  ident: 10.1002/1097-0142(20000815)89:4<826::AID-CNCR15>3.0.CO;2-5-BIB15
  publication-title: Lancet
  doi: 10.1016/S0140-6736(95)91086-7
  contributor:
    fullname: Cuzick
– volume-title: Cervical cancer screening programmes: managerial guidelines
  year: 1992
  ident: 10.1002/1097-0142(20000815)89:4<826::AID-CNCR15>3.0.CO;2-5-BIB4
  contributor:
    fullname: Miller
– volume: 83
  start-page: 2150
  year: 1998
  ident: 10.1002/1097-0142(20000815)89:4<826::AID-CNCR15>3.0.CO;2-5-BIB12
  publication-title: Cancer
  doi: 10.1002/(SICI)1097-0142(19981115)83:10<2150::AID-CNCR13>3.0.CO;2-0
  contributor:
    fullname: Sankaranarayanan
– volume: 80
  start-page: 161
  year: 1999
  ident: 10.1002/1097-0142(20000815)89:4<826::AID-CNCR15>3.0.CO;2-5-BIB11
  publication-title: Int J Cancer
  doi: 10.1002/(SICI)1097-0215(19990105)80:1<161::AID-IJC28>3.0.CO;2-8
  contributor:
    fullname: Sankaranarayanan
– volume: 50
  start-page: 1211
  year: 1997
  ident: 10.1002/1097-0142(20000815)89:4<826::AID-CNCR15>3.0.CO;2-5-BIB9
  publication-title: J Clin Epidemiol
  doi: 10.1016/S0895-4356(97)00122-4
  contributor:
    fullname: Chock
– volume-title: Prevention and control of cervical cancer in the east and southern Africa region
  year: 1998
  ident: 10.1002/1097-0142(20000815)89:4<826::AID-CNCR15>3.0.CO;2-5-BIB17
  contributor:
    fullname: Sanghvi
– volume: 2
  start-page: 87
  year: 1990
  ident: 10.1002/1097-0142(20000815)89:4<826::AID-CNCR15>3.0.CO;2-5-BIB5
  contributor:
    fullname: Reid
– volume: 318
  start-page: 757
  year: 1999
  ident: 10.1002/1097-0142(20000815)89:4<826::AID-CNCR15>3.0.CO;2-5-BIB13
  publication-title: BMJ
  doi: 10.1136/bmj.318.7186.757
  contributor:
    fullname: Kmietowicz
– year: 1999
  ident: 10.1002/1097-0142(20000815)89:4<826::AID-CNCR15>3.0.CO;2-5-BIB1
  contributor:
    fullname: World Health Organization
– volume: 125
  start-page: 672
  year: 1987
  ident: 10.1002/1097-0142(20000815)89:4<826::AID-CNCR15>3.0.CO;2-5-BIB8
  publication-title: Am J Epidemiol
  doi: 10.1093/oxfordjournals.aje.a114580
  contributor:
    fullname: Schatzkin
SSID ssj0007253
Score 2.1563957
Snippet BACKGROUND Noncytologic methods of screening for cervical carcinoma and its precursor lesions are needed for resource‐poor settings in which cervical carcinoma...
Noncytologic methods of screening for cervical carcinoma and its precursor lesions are needed for resource-poor settings in which cervical carcinoma continues...
BACKGROUNDNoncytologic methods of screening for cervical carcinoma and its precursor lesions are needed for resource-poor settings in which cervical carcinoma...
SourceID proquest
crossref
pubmed
pascalfrancis
wiley
SourceType Aggregation Database
Index Database
Publisher
StartPage 826
SubjectTerms Adult
Aged
Biological and medical sciences
cervical intraepithelial neoplasia (CIN)
Cervical Intraepithelial Neoplasia - epidemiology
Cervical Intraepithelial Neoplasia - etiology
cervicography
Cervix
Colposcopy
Demography
Diagnostic Techniques and Procedures
direct visual inspection (DVI)
DNA, Viral - analysis
Evaluation Studies as Topic
Female
Female genital diseases
Gynecology. Andrology. Obstetrics
human papillomavirus
Humans
Mass Screening - methods
Medical sciences
Middle Aged
Neoplasm Invasiveness - prevention & control
Papanicolaou (Pap) smears
Papanicolaou Test
Papillomaviridae - genetics
Papillomaviridae - isolation & purification
Prevalence
squamous intraepithelial lesions (SIL)
Tropical medicine
Tumors
Uterine Cervical Diseases - epidemiology
Uterine Cervical Neoplasms - diagnosis
Uterine Cervical Neoplasms - prevention & control
Vaginal Smears
Title Evaluation of alternative methods of cervical cancer screening for resource‐poor settings
URI https://onlinelibrary.wiley.com/doi/abs/10.1002%2F1097-0142%2820000815%2989%3A4%3C826%3A%3AAID-CNCR15%3E3.0.CO%3B2-5
https://www.ncbi.nlm.nih.gov/pubmed/10951346
https://search.proquest.com/docview/72198004
Volume 89
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwvV1Pi9QwFA_LHhZB_K876moPLughs2mTNMkowtqdZVV2FhYXBjyEJk0uQmeYzlw8-RG8-AX9JL407YwjexFE6CFtIS-8vLz8Xt_rLwi94LZKuc8z7HJFMZN5iiWXKTaALhQppax8-DRwPsnPrtiHKZ_uoGX_L0zkh1h_cAsro_XXYYGXpjnakIaG1CkEwgzaMmuhT6BJUFLB1LJDWgBuhhZcx-9PcDEpLuE1HdMhGRYXh_QdhGDguFMqQh3gyeWGc0pkHXUlkZgzOt1Do07o0Vrky17gK6lG7A2IGo02Yt5GIa9BxNZud3NeNqB4H0_MuA7SbiPkdos7vY1-9MqJlS1fhqulGdqvf_BG_m_t3UG3OsycHEcjv4t2XH0P7Z13VQH30efxmrI8mfmkLQCoW0LzJB6Q3YTHtvWK0I8Nhr5IwF9CDA87dwK4PVl0aYyf377PZ3DfuLYgvHmArk7Hn4oz3B0agS2nIavPKYA4q-CinIDJSW9d5a1g1nFifWAMrIRR0rFcWUG8MMKVvpKSVpaLkj5Eu_WsdvsokaQyQlJjpAE_B4F0iCY9zVJX5qXI8gH62E-unkduEB1ZoLMusQ_61b12tVSaadCr1qBTHXWqqSa6uNCZ5gN0sGUfmy4hglYkG6Dnvb1ocAEhr1PWbrZqNATxCnA_G6BH0Yx-Gw0AaMpgpJPWGP5qmNeOsnvy-F93-ATdiCQHEqf8KdpdLlbuAODe0jxrl-cvQGI0SA
link.rule.ids 314,780,784,1375,27924,27925,46294,46718
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwvV1Pa9swFH90HXSD0f3f0q2rDytsB6e2JdlSNgadm5KuTQqlhcAOwpaly8AJcXLZaR9hp33AfpI-WXayjF4GY-CDLYOeeH56-j29558A3jJVhMzEka9jQXzK49DnjId-juhCBBnnhbFbA8NRPLiiX8ZsvAGL9l8Yxw-x3HCzM6P213aC2w3pgxVrqM2dYiRM8Z5HNfaxPAmCC_y2dJ-kCJzxDq_DkyM_HaUX-Jr0STfopuf75DPGYHfgLvqJ0FaCHV2sWKeSqCGvDLjPKBlvQa-RerCU-a6V-J6LHv2Isnq9lZxPTsoHlLG23j2YZhWq3rgzM24DtesYuV7kjh_Cr1Y9rrblW3cxz7vq-x_Mkf9df49gu4HN3qGz88ewocsnsDVsCgOewtf-krXcmxivrgEoa05zz52RXdlmVTtG7EdZW5956DIxjMfF20Po7s2aTMb1j5_TCT5Xuq4Jr57B1XH_Mh34zbkRvmLEJvYZQRynBF6EBWh13ChdGJVQpVmgjCUNLJJccE1joZLAJHmiM1NwTgrFkow8h81yUuqX4PGgyBNO8pzn6OowlrYBpSFRqLM4S6K4A6ft15VTRw8iHRF01OT2Ub-y1a7kQlKJepUSdSqdTiWRgUzPZSRZB3bXDGTVJQbRIog6sNcajEQvYFM7Wakni0piHC8Q-tMOvHB29NtoEEMTiiMd1dbwV8O8dZRNy86_7nAP7g0uh2fy7GR0-gruO84D7ofsNWzOZwu9i-hvnr-p5-oNvgI4aQ
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwvV1Pa9swFH90HYTB2P8_2dbVhxW2g1PbkmwpHYPOSWjXNR1lhcAOwpaly8AJcXLZaR9hl37BfpI-WXayjF4GY-CDLIOeeHp6-j09-SeAN0wVITNx5OtYEJ_yOPQ546GfI7oQQcZ5YezWwOk4PrqgnyZssgWL9l8Yxw-x2nCzM6P213aCzwqzvyYNtalTDIQplnlUQx9LkyC4wKGleyRF3IwlfA6PB346Ts_xMxmSXtBLz_bIRwzBbsFtGkfCMu4PztekU0nUcFcG3GeUTDrQb6Tur2S-bSW-46JP36Osfn8t54OTcoAyNpa7u7OsQs0bd2XGTZh2EyLXa9zoPly22nFHW773lou8p378QRz5v9X3AO41oNk7dFb-ELZ0-Qg6p82xgMfwbbjiLPemxqtPAJQ1o7nnbsiubLWq3SK2o6ylzz10mBjE49LtIXD35k0e4-rnr9kU3ytdnwivnsDFaPg1PfKbWyN8xYhN6zOCKE4JfAgL0Oa4UbowKqFKs0AZSxlYJLngmsZCJYFJ8kRnpuCcFIolGXkK2-W01M_B40GRJ5zkOc_R0WEkbcNJQ6JQZ3GWRHEXTtrBlTNHDiIdDXTUZPZRv7LVruRCUol6lRJ1Kp1OJZGBTM9kJFkXdjbsY90khtAiiLqw29qLRB9gEztZqafLSmIULxD40y48c2b0W28QQROKPR3XxvBX3byxl03Ni3_d4C50vgxG8vPx-OQl3HGEB9wP2SvYXsyXegeh3yJ_Xc_Ua7ZfNxg
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Evaluation+of+alternative+methods+of+cervical+cancer+screening+for+resource-poor+settings&rft.jtitle=Cancer&rft.au=Denny%2C+L&rft.au=Kuhn%2C+L&rft.au=Pollack%2C+A&rft.au=Wainwright%2C+H&rft.date=2000-08-15&rft.issn=0008-543X&rft.volume=89&rft.issue=4&rft.spage=826&rft_id=info:doi/10.1002%2F1097-0142%2820000815%2989%3A4%3C826%3A%3AAID-CNCR15%3E3.0.CO%3B2-5&rft_id=info%3Apmid%2F10951346&rft.externalDocID=10951346
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0008-543X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0008-543X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0008-543X&client=summon